Nordicus Partners Corp
Price data unavailable
Track NORD in your trading journalAbout Nordicus Partners Corp
Nordicus Partners Corp (NORD) is a US-listed equity tracked across major market indices. NORDICUS PARTNERS CORP
The company reports trailing twelve-month revenue of $763,000 and net loss of $1.23M. Key metrics include a return on equity of -1.9%, a debt-to-equity ratio of 0.17.
FINOTAUR provides free research summaries, news aggregation, and fundamentals for NORD to support both active traders and long-term investors.
Fundamentals
| Revenue (TTM) | $763,000 |
| Net Income (TTM) | $-1.23M |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | -1.89% |
| Debt-to-Equity | 0.17 |
| Dividend per Share | — |
Recent News
- GlobeNewswire Inc.·Feb 20
Orocidin and Syngene Partner to Accelerate Biotech Innovation
- GlobeNewswire Inc.·Jan 14
Nordicus Partners Corporation Announces Key Milestone in Development of Orocidin’s Breakthrough Treatment for Periodontitis
- GlobeNewswire Inc.·Jun 21
Nordicus Partners Corporation Enters Into A Consultancy Agreement With BIO-CONVERT In Denmark
Want real-time analysis on NORD?
Track it free in your trading journal. Log trades, tag setups, and review your edge.